Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Satellos Bioscience(MSLE) the EBIT is -12.17 M (--%), Miss estimate;the EPS is -0.56 (--%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITMiss expectations
-0.01B--
-0.01B--
-0.00B--%
EPSExceed expectations
-0.56--
-0.5725--
+0.0125--%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf